Eishlon Pharmacon Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 6 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 7.57%
- Profit Growth -81.53%
- Ebitda -44.76%
- Net Worth 0.91%
- Total Assets 47.61%
About Eishlon Pharmacon
Eishlon Pharmacon Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 February 2018 (Six years and 11 months 19 days old ). Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Kumar, Ankit Agrawal, Usha Agrawal, and Two other members serve as directors at the Company.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999HR2018PTC072646
-
Company No.
072646
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Feb 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Eishlon Pharmacon?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Kumar
|
Director | 13-Aug-2018 | Current |
|
Ankit Agrawal
|
Director | 20-Feb-2018 | Current |
|
Usha Agrawal
|
Director | 17-Sep-2018 | Current |
|
Ronit Kumar
|
Director | 20-Feb-2018 | Current |
|
Preeti Agrawal
|
Director | 17-Sep-2018 | Current |
Financial Performance of Eishlon Pharmacon.
Eishlon Pharmacon Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.57% increase. The company also saw a substantial fall in profitability, with a 81.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eishlon Pharmacon?
Unlock access to Eishlon Pharmacon's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Agrawal Life Care Private LimitedAshok Kumar, Ankit Agrawal and 2 more are mutual person
-
Neeramay Foods & Beverages Private Limited
Ronit Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eishlon Pharmacon?
Unlock and access historical data on people associated with Eishlon Pharmacon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eishlon Pharmacon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eishlon Pharmacon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
